Biomerica receives notice of patent allowance in China for potential technology

Biomerica announced that the China National Intellectual Property Administration, CNIPA, has issued a Notice of Allowance for a patent application that covers a development stage information technology system that includes an artificial Intelligence claim aimed at assisting individuals to protect themselves against potential adverse reactions to specific food ingredients. Among other things, the patent claims focus on systems, algorithms and methods to help patients avoid potentially harmful food items based on their unique medical data. The patent encompasses a host of IT methods to evaluate, predict, learn and update the potential health risks associated with consuming specific prepared food items, based on a patient’s medical data. “This notice of patent allowance is a step towards a safer, more informed environment where individuals can confidently navigate their dietary choices.” said Zack Irani the CEO of Biomerica. “This recognition from the Chinese Patent Office of the novel and inventive nature of this technology marks a significant step forward in our longer-term ambition of facilitating happier healthier lives globally.”